Language:

Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis

BMJ, 2011-04, Vol.342 (7804), p.962-962 [Peer Reviewed Journal]

Bolland et al 2011 ;BMJ Publishing Group Ltd 2011 ;Copyright: 2011 © Bolland et al 2011 ;Bolland et al 2011 2011 Bolland et al ;ISSN: 0959-8138 ;EISSN: 1468-5833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.d2040 ;PMID: 21505219

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis
Author: Bolland, Mark J ; Grey, Andrew ; Avenell, Alison ; Gamble, Greg D ; Reid, Ian R
Subjects: Aged ; Bone Density Conservation Agents - adverse effects ; Calcium ; Calcium and bone ; Calcium, Dietary - adverse effects ; Cardiovascular disease ; Cardiovascular diseases ; Cardiovascular Diseases - etiology ; Cardiovascular Diseases - mortality ; Cerebral infarction ; Clinical trials ; Clinical trials (epidemiology) ; Coronary artery disease ; Coronary Disease - etiology ; Coronary Disease - mortality ; Datasets ; Dietary Supplements - adverse effects ; Drug Therapy, Combination ; Drugs: cardiovascular system ; Experimentation ; Female ; Health risk assessment ; Heart diseases ; Humans ; Ischaemic heart disease ; Menopause (including HRT) ; Meta-analysis ; Middle Aged ; Musculoskeletal syndromes ; Myocardial infarction ; Myocardial Infarction - etiology ; Myocardial Infarction - mortality ; Myocardial Revascularization ; Osteoporosis ; Osteoporosis, Postmenopausal - prevention & control ; Placebos ; Post-menopause ; Randomized Controlled Trials as Topic ; Risk Factors ; Stroke ; Stroke - etiology ; Stroke - mortality ; Strokes ; Supplementation ; Vitamin D ; Vitamin D - adverse effects ; Womens health
Is Part Of: BMJ, 2011-04, Vol.342 (7804), p.962-962
Description: Objectives To investigate the effects of personal calcium supplement use on cardiovascular risk in the Women’s Health Initiative Calcium/Vitamin D Supplementation Study (WHI CaD Study), using the WHI dataset, and to update the recent meta-analysis of calcium supplements and cardiovascular risk.Design Reanalysis of WHI CaD Study limited access dataset and incorporation in meta-analysis with eight other studies.Data source WHI CaD Study, a seven year, randomised, placebo controlled trial of calcium and vitamin D (1g calcium and 400 IU vitamin D daily) in 36 282 community dwelling postmenopausal women.Main outcome measures Incidence of four cardiovascular events and their combinations (myocardial infarction, coronary revascularisation, death from coronary heart disease, and stroke) assessed with patient-level data and trial-level data.Results In the WHI CaD Study there was an interaction between personal use of calcium supplements and allocated calcium and vitamin D for cardiovascular events. In the 16 718 women (46%) who were not taking personal calcium supplements at randomisation the hazard ratios for cardiovascular events with calcium and vitamin D ranged from 1.13 to 1.22 (P=0.05 for clinical myocardial infarction or stroke, P=0.04 for clinical myocardial infarction or revascularisation), whereas in the women taking personal calcium supplements cardiovascular risk did not alter with allocation to calcium and vitamin D. In meta-analyses of three placebo controlled trials, calcium and vitamin D increased the risk of myocardial infarction (relative risk 1.21 (95% confidence interval 1.01 to 1.44), P=0.04), stroke (1.20 (1.00 to 1.43), P=0.05), and the composite of myocardial infarction or stroke (1.16 (1.02 to 1.32), P=0.02). In meta-analyses of placebo controlled trials of calcium or calcium and vitamin D, complete trial-level data were available for 28 072 participants from eight trials of calcium supplements and the WHI CaD participants not taking personal calcium supplements. In total 1384 individuals had an incident myocardial infarction or stroke. Calcium or calcium and vitamin D increased the risk of myocardial infarction (relative risk 1.24 (1.07 to 1.45), P=0.004) and the composite of myocardial infarction or stroke (1.15 (1.03 to 1.27), P=0.009).Conclusions Calcium supplements with or without vitamin D modestly increase the risk of cardiovascular events, especially myocardial infarction, a finding obscured in the WHI CaD Study by the widespread use of personal calcium supplements. A reassessment of the role of calcium supplements in osteoporosis management is warranted.
Publisher: England: British Medical Journal Publishing Group
Language: English
Identifier: ISSN: 0959-8138
EISSN: 1468-5833
EISSN: 1756-1833
DOI: 10.1136/bmj.d2040
PMID: 21505219
Source: BMJ Journals
MEDLINE
Alma/SFX Local Collection
ProQuest Central

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis

Bolland et al 2011 ;BMJ Publishing Group Ltd 2011 ;Copyright: 2011 © Bolland et al 2011 ;Bolland et al 2011 2011 Bolland et al ;ISSN: 0959-8138 ;EISSN: 1468-5833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.d2040 ;PMID: 21505219

Searching Remote Databases, Please Wait